At a glance
The FY26 Kidney Cancer Research Program Concept Award funds highly innovative, untested kidney cancer research that addresses at least one listed focus area and one kidney cancer type. Eligible applicants include extramural and intramural U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities, with PIs at or above postdoctoral level. The program expects to fund about 7 awards at a total cost cap of $120,000 each, for up to 1 year, and cost sharing is not required. Preliminary data are not allowed, clinical trials are not allowed, and the review is blinded, with applications that identify the PI, collaborators, or their organizations subject to administrative rejection.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Concept Award supports highly innovative, untested, potentially groundbreaking concepts, theories, paradigms and/or basic kidney cancer research. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in kidney cancer. Applications must describe how the new concept will be innovative and present a novel course of investigation in the field of kidney cancer. Distinctive Features: • Preliminary data are not allowed. • This is a blinded funding mechanism. Applications to this funding opportunity will undergo a double-blinded peer review. Applications must not include any materials that may identify the Principal Investigator (PI), a collaborator, or the organization of the PI or collaborator. • Due to the blinded nature of the review process, identifying or making references to the PI, collaborator(s), or their organization(s) in the proposal (Project Narrative, List of Abbreviations, Acronyms, Symbols, Statement of Work, Impact Statement and Innovation Statement) is prohibited and will result in administrative rejection of the application.
Who can apply
- Unrestricted